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Liquid chromatography - tandem mass spectroscopic method for the determination Of 
zerumbone in human plasma and its application to Pharmacokinetics. 
ABSTRACT 
A rapid, sensitive, specific and selective LC-MS/MS method for the determination of 
zerumbone (ZER) in human plasma using 2,4-diamino-6-(4-methoxyphenyl)-1,3,5-triazine 
(DMTZ) as an internal standard (IS) has been developed and validated. ZER was 
chromatographed on C8 column using a mobile phase of acetonitrile/water (80:20, v/v) at a 
flow rate of 0.25 ml min(-1) . Quantitation was achieved using ESI+ interface, employing 
multiple reaction monitoring (MRM) mode at m/z 219 > 81 and 218 > 134 for ZER and IS, 
respectively. The calibration standards were linear over a range of 5-3000 ng ml(-1) 
(r(2)=0.9994) with an LLOQ of 5 ng ml(-1) (RSD %; 11.4% and bias%; 9.5%). Intra- and 
inter-day precision of ZER assay ranged from 0.18 to 3.56% with accuracy (bias) that varied 
between -5.09 and 4.3%, demonstrating good precision and accuracy. Recoveries of ZER and 
the IS from human plasma were above 85%. The developed method was validated for the 
determination of ZER in rat plasma. Linearity, stability of ZER and the ME on rat plasma 
were discussed. The applicability of the developed method was demonstrated by measuring 
ZER in rat plasma samples following intravenous and intraperitoneal administration of ZER 
prepared in hydroxypropyl-β-cyclodextrin (HPβCD) and sodium carboxymethyl cellulose 
(CMC), respectively, in 20 mg kg(-1) and this study indicated a clear significant difference 
(p<0.05) in pharmacokinetic parameters of ZER in ZER/HPβCD complex compared with 
ZER in CMC preparation. 
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